Eye drop offers new hope for droopy eyelids after facial paralysis
NCT ID NCT05945615
First seen Nov 18, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tested an FDA-approved eye drop (oxymetazoline) to treat droopy eyelids that can happen after facial paralysis. The droopiness occurs because nerves heal abnormally, causing the wrong muscles to tighten. The trial included 36 adults and measured changes in eyelid position, vision, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIAL PARALYSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M.S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
Conditions
Explore the condition pages connected to this study.